ChemWerth, Inc, a global provider of generic active pharmaceutical ingredient (API) development and supply solutions, is strengthening its operations in India with the appointment of Chandrakanth Reddy as General Sales Manager for the region. The move reflects the company’s continued focus on growing its customer base and commercial presence in one of the world’s most significant generic pharmaceutical markets.
Commenting on the appointment, Pete Werth III, President of ChemWerth, said that adding dedicated sales leadership in India underscores the company’s long-term commitment to the market. He noted that Mr Reddy’s experience and industry knowledge will be valuable in supporting customers and contract manufacturing partners across the region.
Mr Reddy brings more than 16 years of experience in the pharmaceutical industry, with a background spanning API sourcing, business development, market growth, and regulatory-focused commercial strategy. Over the course of his career, he has managed key markets across India, the Middle East, North Africa, Europe, and the United States, building strong customer relationships and driving sustained revenue growth.
In his new role, Mr Reddy will oversee ChemWerth’s sales strategy in India, deepen regional customer engagement, and support the introduction of new generic APIs. His focus will include expanding the company’s offerings in fermentation, peptide, and oncology injectable APIs. Mr Reddy said he was drawn to ChemWerth’s clear strategy and strong pipeline of upcoming generic products tailored for the Indian market, adding that he looks forward to contributing to the company’s growth in the region.
Founded in 1982, ChemWerth is a full-service generic API development and supply company delivering cGMP-compliant APIs to regulated markets worldwide. The company is headquartered in the United States and operates offices in China and India.
